You are here

Home » Content

Sürekli Ayaktan Periton Diyalizi (SAPD) Uygulanan Hastaların Nazal Örneklerinden İzole Edilen Stafilokoklarda Slime Oluşumu, Mupirosin ve Diğer Antibiyotiklere Duyarlılığın Araştırılması

Slime Production, Mupirocin and other Antibiotics Susceptibilities in Staphylococci Isolated from Nasal Samples in Patients Receiving Continuous Ambulatory Peritoneal Dialysis (CAPD)

Journal Name:

  • İnönü Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2010

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
The aim of this study was to determine the prevalence of slime producingand to determine the mupirocin and other antibiotic susceptibilities of Staphylococcus aureus (S. aureus) and Coagulase negative staphylococci (CNS) strains isolated from nasal samples of patients on CAPD. This study was conducted at the Inonu University Medical Center, Microbiology Laboratory, Malatya, Turkey, between December 2007 and April 2008. Nasal swab cultures were taken from 72 CAPD patients to establish the prevalence of nasal staphylococci carriage. Fifty-one (70.8%) nasal culture were positive for staphylococci species. Between them 45 (76.2%) strains were identified as CNS and 14 (23.7%) strains were identified as S. aureus . Nineteen cultures were slime positive. The methicillin resistance rate for CNS strains was detected as 93% and S. aureus strains was detected as 50%. Five of the staphylococci strains were resistant to mupirocin. Resistance to multiple antibiotics was detected in both the slime producing and methicillin resistant staphylococci. Detection of staphylococci nasal carriage in CAPD patients and to get all precautions may be useful to prevent the infections with these microorganisms.
Bookmark/Search this post with
Abstract (Original Language): 
Bu çalışmanın amacı; sürekli periton diyalizi tedavisi alan hastaların nazal kültürlerinden izole edilen Staphylococcus aureus (S. aureus) ve koagulaz negatif stafilokoklarda (KNS) slime oluşumunu ve mupirosin ile diğer antibiyotiklere duyarlılıklarını araştırmaktır. Çalışma; Aralık 2007-Nisan 2008 tarihleri arasında, Malatya’da İnönü Üniversitesi Tıp Merkezi, Mikrobiyoloji Laboratuvarında yapıldı. Nazal stafilokok taşıyıcılığını belirlemek için, SAPD uygulayan 72 hastadan nazal kültürler alındı. Nazal kültür yapılan hastaların 51(%70.8)’inde stafilokok türleri üredi. Stafilokok üreyen 51 örneğin 45 (%76.2)‘i KNS, 14 (%23.7)’ü S. aureus olarak tanımlandı. Metisilin direnci KNS için %93, S. aureus için %50 olarak saptandı. Ondokuz örnekte slime pozitif bulundu. Beş izolat mupirosin’e dirençli bulundu. Hem slime pozitif hem de metisiline dirençli olan örneklerde antibiyotiklere çoklu direnç bulunduğu saptandı. Sürekli periton diyalizi yapılan hastalarda nazal stafilokok taşıyıcılığının belirlenmesi ve gerekli önlemlerin alınması, bu mikroorganizma enfeksiyonlarının önlenmesinde faydalı olacaktır.
FULL TEXT (PDF): 
PDF icon arastirmax-surekli-ayaktan-periton-diyalizi-sapd-uygulanan-hastalarin-nazal-orneklerinden-izole-edilen-stafilokoklarda-slime-olusumu-mupirosin-diger-antibiyotiklere-duyarliligin.pdf
  • 1
33-36
  • Turkish

REFERENCES

References: 

1. Akman S, Bakkaloğlu SA, Ekim M, Sever L, Noyan A, Aksu N.
Peritonitis rates and common microorganisms in continuous
ambulatory peitoneal dialysis and automated peritoneal dialysis.
Pediatr Int 2009; 5(2): 246-9.
2. Williams JD, Coles GA. Gram-positive infections related to
CAPD. J Antimicrob Chemother 1991; 27: 31-5.
3. Kavanagh D, Prescott GJ, Mactier RA. Peritonel dialysis
associated peritonitisin Scotland.Nephrol Dial Transplant 2004;
19: 2584-91.
4. Lederer SR, Riedelsdorf G, Schffl H. Nasal carriage of
methicillin resistant S. Aureus: the prevalance, patients at risk
and the effect of elimination on outcomes among outclinic
haemodialysis patients. Eur j Med Res 2007; 12(7):284-8.
5. Çavdar C, Sağlam F, Sifil A, Çelik A, Atay T, Gungor O ve ark.
Effect of once-a-week vs thrice a-week application of
mupirocin on methicillin and mupirocin resistance in peritoneal
dialysis patients: three years of experience. Ren Fail 2008; 30(4):
417-22.
6. Bannerman TL. Staphylococcus, micrococcus, and other
catalase-positive cocci that grow aerobically. In: Murray PR,
Baron EJ, Jorgensen JH, Pfaller, MA, Yolken RH. eds. Manuel
of Clinical Microbiology, 8.th edition, Washington: ASM, 2003:
384-404.
7. Akiyama H, Yamasaki O, Kanzaki H, Tada J, Arata J.
Adherence characteristics of Staphylococcus aureus and
coagulase negative staphylococci isolated from various skin
lesions. Journ Derm Sci 1998; 18(2):132-6.
8. Christensen GD, Simpson WA, Bisno AL, Beachey EH.
Adherence of slime-producing strains of Staphylococcus
epidermidis to smooth surfaces. Infect Immun 1982;37: 318-26
9. Antimikrobik Duyarlılık Testleri İçin Uygulama Standartları;
Onyedinci Bilgi Eki, Gür D. (ed) Ankara, Bilimsel Tıp Yayınevi,
2007; 44-51.
10. Creagh S, Lucey B. Interpretive criteria for mupirocin
susceptibility testing of Staphylococcus spp. using CLSI
guidelines. Br J Biomed Sci 2007 ; 64:1-5.
11. Nakamura M, Watanabe Y, Osono E, Ohwada K, Kurihara S,
Toume K, et al. Clonotypes of Staphylococcus aureus isolated
from continuous ambulatory peritoneal dialysis patients: what is
the vector between nares and infection site? Adv Perit Dial
2006; 16 :48-51.
12. Laurain C, Durand YP, Albert M, Weber M, Kessler M,
Chanliau J, et al. Infection peritonitis in patients undergoing
continuous ambulatory peritoneal dialysis: microbiological
review during a four-year period. Pathol Biol 2004;2: 575-8.
13. Şencan İ, Kaya D, Çatakoğlu N, Şahin İ, Bahtiyar Z, Yıldırım
M. Hemodiyaliz hastalarında burunda MRSA taşıyıcılığı.
İnfeksiyon Dergisi 2003;17(1): 31-4.
14. Baretti P, Montelli AC, Batalha JE, Caramori JC, Cunha M deL.
The role of virulence factors in the outcome of staphylococcal
peritonitis in CAPD patients. BJM Infect Dis 2009;22 (9): 212-
5.
Ay ve ark.
36
15. Schmitz FJ, Lindenlauf E, Hoffmann B, Fluit AC, Verhoet J,
Heinz HP, et al. The prevalance of low-and high level
mupirocin resistance in staphylococci from 19 European
hospitals. J Antimicrob Chemoter 1998;42: 489-95.
16. Oğuzkaya-Artan M, Gülgün M, Baykan Z, Tok D. Hastane
çalışanlarında S. aureus burun taşıyıcılığı ve antibiyotik
duyarlılığının araştırılması. İnfek Derg 2008;22(2): 87-90.
17. Vardar G, Ünlü M, Yağmuroğlu A. Klinik örneklerden
soyutlanan S. aureus ve KNS izolatlarında mupirosin direnci.
Ankem Derg 2006;20(4):222-5.
18. Us T, Kural M, Yayla B, Kiremitçi A, Çetin E, Akgün Y.
Investigation of mupirocin resistance in nosocomial methicillinresistant
S. aureus isolates by phenotypic and genotypic
methods. Mikrobiol Bül 2009; 3(3): 353-64.
19. Patel JB, Gorwitz RJ, Jernigan JA. Mupirocin resistance. Clin
Infect Dis 2009; 49(6): 935-41.
20. Xu G, Tu W, Xu C. Mupirocin for preventing exit-cite infection
and peritonitis in patients undergoing peritoneal dialysis.
Nephrol Dial Transplant 2010; 25(2): 587-92

Thank you for copying data from http://www.arastirmax.com